Category: Video | CATIE Blog

Sexual health for all: Lessons from the HIV & STI 2025 World Congress

October 16, 2025 • By Dan Miller

This July, CATIE joined 1,500 researchers, advocates and policy makers from around the world for the STI and HIV 2025 World Congress in Montreal, Quebec. Held every two years, the event provides a venue for global leaders in sexual health research to discuss the latest evidence and most pressing challenges in STI prevention, testing and care. Four particularly timely and significant topics stood out, each with important implications for bacterial STI prevention, testing and treatment. DoxyPEP for cis women A key theme of the event was the lack of research on doxycycline post-exposure prophylaxis (doxyPEP) effectiveness in cis women and...

Global lessons on harm reduction policy and practice: Interview videos from the Harm Reduction International Conference

August 5, 2025 • By Christopher Hoy

CATIE attended the recent Harm Reduction International Conference (HR25) in Bogotá, Colombia. This long-running conference brings together researchers, health workers, policymakers and community experts from around the world. Four days of presentations, workshops, networking and art installations created a dynamic forum to share research and practice on harm reduction, drug policy and human rights. Organized around the theme “Sowing Change to Harvest Justice”, the conference explored the intersections of social justice, equity and peace in the context of drug policy. CATIE spoke with presenters and attendees to hear key perspectives and learnings on three themes from HR25: harm reduction and...

Routine practice, big impact

April 28, 2025 • By Fozia Tanveer

What if a simple change in routine could save lives? For many immigrants to Canada, access to timely healthcare isn’t just a matter of convenience – it’s a matter of survival. Some immigrants are up to four times more likely to have hepatitis C than the Canadian average, and up to six times more likely to have hepatitis B. But because their risk factors are usually different from those born in Canada, they are often overlooked in Canadian screening programs. Enter CATIE’s Routine Practice campaign, designed to change the way Canadian healthcare providers approach viral hepatitis screening. By blending data-driven...

The impact of hepatitis C on women: Learnings from the CanHepC 2025 Symposium

April 28, 2025 • By Madison Kennedy

In February, CATIE attended the 14th Canadian Symposium on Hepatitis C, which was hosted by the Canadian Network for Hepatitis C (CanHepC) as part of the Canadian Liver Meeting. This national conference brought experts from across the country to Quebec City, where they showcased the latest in hepatitis C research. The symposium highlighted diverse perspectives on the theme “Hepatitis C in Women” from clinicians, researchers and people with lived and living experience of hepatitis C and substance use. During the event, CATIE asked presenters and attendees to share key takeaways from the conference about this important topic. Watch the short...

Strong Medicine: Seven years later

November 13, 2024 • By Danita Wahpoosewyan and Trevor Stratton

In 2018, CATIE and CAAN (Communities, Alliances & Networks) released Strong Medicine, a film by and for Indigenous people living with HIV. The film weaves together Indigenous knowledges of culture and wellness with Western knowledge of HIV testing and treatment. By sharing their experiences with Indigenous and Western medicines, eight Indigenous activists teach us that HIV isn’t something to be feared and show us different ways to walk the healing path. Seven years after Strong Medicine was released, CATIE spoke with two of its stars, Danita Wahpoosewyan and Trevor Stratton, to reflect on what has changed, what has remained the...

Tackling misconceptions: Hepatitis C treatment for people who use drugs

April 22, 2024 • By Romane Close

With the advent of treatments called direct-acting antivirals (DAAs), a huge number of people across Canada have been successfully cured of hepatitis C. However, efforts to cure some of the most affected communities continue to be hindered by incorrect or outdated information. For example, many successes in curing hepatitis C have been achieved through the determination of people who use drugs, and yet they still encounter access barriers due to discrimination and problematic misconceptions around treatment eligibility. These gaps in knowledge can be addressed by raising awareness about hepatitis C treatment and organizations across Canada have been working to clarify...